First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor

por Perera, Vidya, Wang, Zhaoqing, Luettgen, Joseph, Li, Danshi, DeSouza, Mary, Cerra, Michael, Seiffert, Dietmar
Publicado 2021

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation

por Wilson, Simon J., Ismat, Fraz A., Wang, Zhaoqing, Cerra, Michael, Narayan, Hafid, Raftis, Jennifer, Gray, Timothy J., Connell, Shea, Garonzik, Samira, Ma, Xuewen, Yang, Jing, Newby, David E.
Publicado 2018